Christopher Michael Cashman
Chairman chez MBF Therapeutics, Inc.
Profil
Christopher Michael Cashman is the founder of Protez Pharmaceuticals, Inc. which was founded in 2003.
He is currently the Chairman at MBF Therapeutics, Inc., Director at Phoenix S&T, Inc., University City Science Center, Life Sciences Pennsylvania, Science Center of Iowa, Noble Biomaterials, Inc., Greater Philadelphia Life Sciences Congress, and Polycore Therapeutics, Inc. He is also an Advisor at Grays Ferry GP, LLC.
Mr. Cashman's former positions include President, Chief Executive Officer & Director at Marinus Pharmaceuticals, Inc., President & Chief Executive Officer at Message Pharmaceuticals, Inc., Director at Rapid Micro Biosystems, Inc., Director at JDP Therapeutics LLC, Director at Locus Pharmaceuticals, Inc., Vice President-Sales & Marketing at Pfizer Inc. and Smithkline Beecham Plc, and Principal at Quaker Partners LLC.
Mr. Cashman has a graduate degree from Purdue University and an undergraduate degree from the University of Minnesota.
Postes actifs de Christopher Michael Cashman
| Sociétés | Poste | Début |
|---|---|---|
Phoenix S&T, Inc.
 Phoenix S&T, Inc. Medical/Nursing ServicesHealth Services Phoenix S&T, Inc. develops and sells injection molded nanospray devices. It offers and markets high-throughput, robust manual and automated micro/nanospray single and dual-column sources, as well as column heaters, column heat controllers, and non-clogging nanospray emitters to deliver excellent micro/nanoLC/MS performance in proteomics and biomarker discovery research. The company was founded in 2001 and is headquartered in Chester, PA. | Director/Board Member | 18/03/2011 |
University City Science Center
 University City Science Center Investment Trusts/Mutual FundsMiscellaneous University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA. | Director/Board Member | 17/06/2011 |
| Greater Philadelphia Life Sciences Congress | Director/Board Member | 25/07/2011 |
Noble Biomaterials, Inc.
 Noble Biomaterials, Inc. TextilesProcess Industries Noble Biomaterials, Inc. provides bacterial management solutions. It develops, manufactures, sells and markets antimicrobial technologies designed to manage all forms of bacterial contamination for medical, defense, industrial and consumer markets. The firm also manufactures its own line of wound care bandages and dressing and markets them under the brands SilverSeal, CircuiteX, and ContaX. The company was founded in 1997 by Joel M. Furey and William F. McNally and is headquartered in Scranton, PA. | Director/Board Member | - |
MBF Therapeutics, Inc.
 MBF Therapeutics, Inc. Agricultural Commodities/MillingProcess Industries MBF Therapeutics, Inc. develops and provides veterinary oncology products. It develops and commercializes proprietary checkpoint inhibitor immunotherapy technology based on vaccines and vaccine adjuvants. The company was founded by Thomas Tillett and Travis Meredith in 2008 and is headquartered in Ambler, PA. | Chairman | - |
| Science Center of Iowa | Director/Board Member | - |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Director/Board Member | - |
Polycore Therapeutics, Inc.
 Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | Director/Board Member | - |
Grays Ferry Capital
 Grays Ferry Capital Investment ManagersFinance Grays Ferry GP LLC (Grays Ferry Capital) is a venture capital firm founded in 2019 by Jeffrey Cheung and Vincent Wong. Grays Ferry Capital is headquartered in Philadelphia, Pennsylvania. | Consultant / Advisor | - |
Anciens postes connus de Christopher Michael Cashman
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Christopher Michael Cashman
| Purdue University | Graduate Degree |
| University of Minnesota | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| MARINUS PHARMACEUTICALS, INC. | Health Technology |
| RAPID MICRO BIOSYSTEMS, INC. | Producer Manufacturing |
| Entreprise privées | 16 |
|---|---|
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
Quaker Partners LLC
 Quaker Partners LLC Investment ManagersFinance Part of GWA LLC, Quaker Partners LLC is a venture capital fund. The private company is based in Hartford, CT. | Finance |
Phoenix S&T, Inc.
Phoenix S&T, Inc. Medical/Nursing ServicesHealth Services Phoenix S&T, Inc. develops and sells injection molded nanospray devices. It offers and markets high-throughput, robust manual and automated micro/nanospray single and dual-column sources, as well as column heaters, column heat controllers, and non-clogging nanospray emitters to deliver excellent micro/nanoLC/MS performance in proteomics and biomarker discovery research. The company was founded in 2001 and is headquartered in Chester, PA. | Health Services |
JDP Therapeutics LLC
 JDP Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDP Therapeutics Inc. is a privately held, specialty pharmaceutical company focused on developing and commercializing proprietary product candidates for the treatment of life threatening diseases with significant unmet medical needs, principally for use in the hospital and urgent care settings. The company was founded by Jie Du in 2009 and is headquartered in Lansdale, PA. | Health Technology |
MBF Therapeutics, Inc.
MBF Therapeutics, Inc. Agricultural Commodities/MillingProcess Industries MBF Therapeutics, Inc. develops and provides veterinary oncology products. It develops and commercializes proprietary checkpoint inhibitor immunotherapy technology based on vaccines and vaccine adjuvants. The company was founded by Thomas Tillett and Travis Meredith in 2008 and is headquartered in Ambler, PA. | Process Industries |
Locus Pharmaceuticals, Inc.
 Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Health Technology |
Protez Pharmaceuticals, Inc.
 Protez Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Protez Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It develops antibiotics for infections & provides research service on intravenous & oral small molecule antibiotics to chronic and recurrent infections. The company was founded by Klaus Esser, Luigi Xerri & Christopher M. Cashman in 2003 and is headquartered in Malvern, PA. | Health Technology |
University City Science Center
University City Science Center Investment Trusts/Mutual FundsMiscellaneous University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA. | Miscellaneous |
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Commercial Services |
Message Pharmaceuticals, Inc.
 Message Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Message Pharmaceuticals, Inc. develops pharmaceutical drugs. It operates as research development company involved in RNA research and exploring other types of RNAs to look for RNA-binding proteins, especially to combat RNA viruses and to treat all major disease categories. Message Pharmaceuticals was founded in 2002 and is located in Malvern, PA | Health Technology |
| Science Center of Iowa | |
Noble Biomaterials, Inc.
Noble Biomaterials, Inc. TextilesProcess Industries Noble Biomaterials, Inc. provides bacterial management solutions. It develops, manufactures, sells and markets antimicrobial technologies designed to manage all forms of bacterial contamination for medical, defense, industrial and consumer markets. The firm also manufactures its own line of wound care bandages and dressing and markets them under the brands SilverSeal, CircuiteX, and ContaX. The company was founded in 1997 by Joel M. Furey and William F. McNally and is headquartered in Scranton, PA. | Process Industries |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
| Greater Philadelphia Life Sciences Congress | |
Polycore Therapeutics, Inc.
Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | Health Technology |
Grays Ferry Capital
Grays Ferry Capital Investment ManagersFinance Grays Ferry GP LLC (Grays Ferry Capital) is a venture capital firm founded in 2019 by Jeffrey Cheung and Vincent Wong. Grays Ferry Capital is headquartered in Philadelphia, Pennsylvania. | Finance |
